The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort

被引:0
|
作者
Senkaali, D
Muwonge, R
Morgan, D
Yirrell, D
Whitworth, J
Kaleebu, P
机构
[1] Uganda Virus Res Inst, MRC, Programme AIDS, Entebbe, Uganda
[2] Univ Edinburgh, Ctr HIV Res, Edinburgh EH9 3JN, Midlothian, Scotland
关键词
D O I
10.1089/0889222042222827
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigenic properties of the V3 region are reflected by HIV-1 serotypes. These may represent biological properties of the virus. We serotyped HIV-1 in 142 serum samples from participants in a rural Uganda cohort who seroconverted between August 1991 and December 2001. Clinical progression was assessed using Cox proportional hazards and Kaplan - Meier methods. Of 112 (79%) samples successfully serotyped, 36% were serotype A, 17% serotype B, 18% serotype C, and 29% serotype D. Median follow-up time, age at enrollment, and first CD4 count were similar in each serotype group. Clinical progression was faster for serotype D than other serotypes to AIDS or death, death, and CD4 count <200 cells/mm(3) (all p< 0.05). HIV-1 V3 serotypes are associated with variations in the pathogenicity of HIV-1 and should be taken into account when studying the biological relevance of HIV-1 diversity.
引用
收藏
页码:932 / 937
页数:6
相关论文
共 50 条
  • [21] HIV disease progression and V3 serotypes in Brazil:: Is B different from B-Br?
    Santoro-Lopes, G
    Harrison, LH
    Tavares, MD
    Xexéo, A
    Dos Santos, ACE
    Schechter, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (10) : 953 - 958
  • [22] RELATIONSHIP BETWEEN THE V3 LOOP AND THE PHENOTYPES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ISOLATES FROM CHILDREN PERINATALLY INFECTED WITH HIV-1
    MAMMANO, F
    SALVATORI, F
    OMETTO, L
    PANOZZO, M
    CHIECOBIANCHI, L
    DEROSSI, A
    JOURNAL OF VIROLOGY, 1995, 69 (01) : 82 - 92
  • [23] Variation in HIV type 1 V3 region env sequences from Mozambique
    Engelbrecht, S
    Koulinska, I
    Smith, TL
    Barreto, J
    Van Rensburg, EJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (09) : 803 - 805
  • [24] HIV-1 subtype dynamics over 10 years in a rural Ugandan cohort
    Yirrell, DL
    Kaleebu, P
    Morgan, D
    Hutchinson, S
    Whitworth, JA
    INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (02) : 103 - 106
  • [25] HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages
    Benjouad, A
    Seddiki, N
    Ylisastigui, L
    Gluckman, JC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (03) : 219 - 226
  • [26] DECREASING HIV-1 SEROPREVALENCE IN YOUNG-ADULTS IN A RURAL UGANDAN COHORT
    MULDER, D
    NUNN, A
    KAMALI, A
    KENGEYAKAYONDO, J
    BRITISH MEDICAL JOURNAL, 1995, 311 (7009): : 833 - 836
  • [27] ALGORITHMS FOR DETECTING ANTIBODIES TO HIV-1 - RESULTS FROM A RURAL UGANDAN COHORT
    NUNN, AJ
    BIRYAHWAHO, B
    DOWNING, RG
    VANDERGROEN, G
    OJWIYA, A
    MULDER, DW
    AIDS, 1993, 7 (08) : 1057 - 1061
  • [28] CONFORMATIONAL ASPECTS OF V3 IN HIV-1 NEUTRALIZATION
    REITZ, M
    VERONESE, FD
    LOUIE, A
    WATKINS, B
    GUPTA, G
    LUSSO, P
    GALLO, RC
    ROBERTGUROFF, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S39 - S39
  • [29] CONFORMATIONAL ASPECTS OF V3 IN HIV-1 NEUTRALIZATION
    REITZ, M
    ROBERTGUROFF, M
    DIMARZOVERONESE, F
    LOUIE, A
    WATKINS, B
    GUPTA, G
    LUSSO, P
    GALLO, RC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 217 - 217
  • [30] Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage
    Verrier, F
    Borman, AM
    Brand, D
    Girard, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (08) : 731 - 743